Safety and Varicella Outcomes in In Utero-Exposed Newborns and Preterm Infants Treated With Varicella Zoster Immune Globulin (VARIZIG): A Subgroup Analysis of an Expanded-Access Program.

Find People
Find Research
Overview
Tutorials
FAQs
Edit My PROFILE
Login to PROFILES

Contact Us
If you have any questions or feedback please contact us.

Safety and Varicella Outcomes in In Utero-Exposed Newborns and Preterm Infants Treated With Varicella Zoster Immune Globulin (VARIZIG): A Subgroup Analysis of an Expanded-Access Program.

Duchon JM, Levin MJ, Gershon AA. Safety and Varicella Outcomes in In Utero-Exposed Newborns and Preterm Infants Treated With Varicella Zoster Immune Globulin (VARIZIG): A Subgroup Analysis of an Expanded-Access Program. J Pediatric Infect Dis Soc. 2020 Sep 17; 9(4):449-453.

View in: PubMed

subject areas

Adult
Child, Preschool
Female
Herpes Zoster
Humans
Immune Sera
Infant
Infant, Newborn
Infant, Premature
Infectious Disease Transmission, Vertical
Male
Patient Safety
Post-Exposure Prophylaxis
Pregnancy
Pregnancy Complications, Infectious

authors with profiles

Myron J Levin

Contact Us
CCTSI
About CCTSI
CCTSI Affiliated Institutions
National CTSA Consortium